Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Surgical resection and liver transplantation are the main treatment options, however, the results are limited, and the prognosis is poor, mainly due to late diagnosis. Nonspecific or absent symptoms in HCC require monitoring of individuals at high risk using ultrasound and alpha-fetoprotein (AFP) …